Analysts say the partial U.S.-China trade deal doesn't touch on thorny issues plaguing both sides, and warn talks could break down again.World Economyread more
Economists polled by Reuters had expected Chinese exports denominated in the U.S. dollar to fall by 3% and imports to decline by 5.2% in September, compared to a year ago.China Economyread more
The U.S. had plans to hike duties on at least $250 billion in Chinese goods to 30% from 25% on Tuesday. Despite the partial trade deal, some banks on Sunday wrote that tariff...Marketsread more
The industry has pulled in $322 billion over the past six months, the fastest pace since the second half of 2008.Marketsread more
A technical recession occurs when there are two consecutive quarters of economic contraction.Asia Economyread more
"Deepfakes" are being used to depict people in fake videos they did not actually appear in, and can potentially affect elections, diplomacy and how markets move, experts say.Technologyread more
Chinese President Xi Jinping warned on Sunday that any attempt to divide China will be crushed.China Politicsread more
Syria's Kurds said Syrian government forces agreed Sunday to help them fend off Turkey's invasion.World Newsread more
U.S. President Donald Trump said that both sides reached a "very substantial phase one deal" that will address intellectual property and financial services concerns and...Asia Marketsread more
Hagibis dropped record amounts of rain for a period in some spots, according to meteorological officials, causing more than 20 rivers to overflow.Asia Newsread more
A spokesperson for the U.S.-backed Syrian Democratic Forces (SDF) has issued a stark warning to the international community.World Newsread more
Billionaire investor William Ackman's portfolios climbed nearly 6 percent in August, boosted by strong gains at drug company Valeant Pharmaceuticals where changes that the hedge fund manager has helped push for appear to be instilling new confidence.
Pershing Square Holdings, one of the hedge fund's portfolios, climbed 5.8 percent last month, shrinking its loss for the year to 14.3 percent, an investor in the fund said. In March the fund had been down 25.6 percent.
Valeant gained roughly 39 percent in the last month.
A year ago, Valeant's stock began cratering amid questions about the company's business and accounting practices and its stock price is still down 87 percent in the last 52 weeks. In the last few weeks, it began recovering as the company's new chief executive officer eased worries about a possible default and the company hired a new chief legal officer and chief financial officer.
Other hedge funds also told their clients that they scored gains in August. Jana Partners, an activist fund like Ackman's Pershing Square, was up 1 percent in August, shrinking its year to date loss to 3 percent, an investor in the fund said.
Citadel's Wellington fund gained 2.4 percent in August and is now up 0.5 percent for the year, a person familiar with the figures said.